These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 20801033
1. Probing the active-site requirements of human intestinal N-terminal maltase glucoamylase: the effect of replacing the sulfate moiety by a methyl ether in ponkoranol, a naturally occurring α-glucosidase inhibitor. Eskandari R, Jones K, Rose DR, Pinto BM. Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5686-9. PubMed ID: 20801033 [Abstract] [Full Text] [Related]
2. Potent glucosidase inhibitors: de-O-sulfonated ponkoranol and its stereoisomer. Eskandari R, Kuntz DA, Rose DR, Pinto BM. Org Lett; 2010 Apr 02; 12(7):1632-5. PubMed ID: 20218632 [Abstract] [Full Text] [Related]
3. Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de-O-sulfonated derivative. Mohan S, Sim L, Rose DR, Pinto BM. Bioorg Med Chem; 2010 Nov 15; 18(22):7794-8. PubMed ID: 20970346 [Abstract] [Full Text] [Related]
4. The effect of heteroatom substitution of sulfur for selenium in glucosidase inhibitors on intestinal α-glucosidase activities. Eskandari R, Jones K, Rose DR, Pinto BM. Chem Commun (Camb); 2011 Aug 28; 47(32):9134-6. PubMed ID: 21750824 [Abstract] [Full Text] [Related]
5. New chain-extended analogues of salacinol and blintol and their glycosidase inhibitory activities. Mapping the active-site requirements of human maltase glucoamylase. Nasi R, Sim L, Rose DR, Pinto BM. J Org Chem; 2007 Jan 05; 72(1):180-6. PubMed ID: 17194097 [Abstract] [Full Text] [Related]
6. Probing the intestinal α-glucosidase enzyme specificities of starch-digesting maltase-glucoamylase and sucrase-isomaltase: synthesis and inhibitory properties of 3'- and 5'-maltose-extended de-O-sulfonated ponkoranol. Eskandari R, Jones K, Reddy KR, Jayakanthan K, Chaudet M, Rose DR, Pinto BM. Chemistry; 2011 Dec 23; 17(52):14817-25. PubMed ID: 22127878 [Abstract] [Full Text] [Related]
9. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Sim L, Jayakanthan K, Mohan S, Nasi R, Johnston BD, Pinto BM, Rose DR. Biochemistry; 2010 Jan 26; 49(3):443-51. PubMed ID: 20039683 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of heteroanalogues of kotalanol and de-O-sulfonated kotalanol. Mohan S, Jayakanthan K, Nasi R, Kuntz DA, Rose DR, Pinto BM. Org Lett; 2010 Mar 05; 12(5):1088-91. PubMed ID: 20143790 [Abstract] [Full Text] [Related]
12. New synthetic routes to chain-extended selenium, sulfur, and nitrogen analogues of the naturally occurring glucosidase inhibitor salacinol and their inhibitory activities against recombinant human maltase glucoamylase. Liu H, Nasi R, Jayakanthan K, Sim L, Heipel H, Rose DR, Pinto BM. J Org Chem; 2007 Aug 17; 72(17):6562-72. PubMed ID: 17658854 [Abstract] [Full Text] [Related]
17. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents. Mohan S, Eskandari R, Pinto BM. Acc Chem Res; 2014 Jan 21; 47(1):211-25. PubMed ID: 23964564 [Abstract] [Full Text] [Related]
18. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. Sim L, Quezada-Calvillo R, Sterchi EE, Nichols BL, Rose DR. J Mol Biol; 2008 Jan 18; 375(3):782-92. PubMed ID: 18036614 [Abstract] [Full Text] [Related]